Cameroon’s Prime Minister and Minister of Public Health, Dr. Jean-Eric Kouame, visited the construction site of the future pharmaceutical factory in Meyo to assess the progress of a strategic industrial project aimed at strengthening the nation’s health sovereignty.
The visit focused on the ongoing works at the facility, which is designed to enhance the country’s capacity to produce essential medicines locally. By establishing this manufacturing hub, the government seeks to reduce reliance on imported drugs and ensure a more stable supply chain for critical healthcare needs.
During the tour, officials examined the current state of the infrastructure, highlighting the project’s role in the broader national strategy for industrial development. The Meyo facility represents a significant step toward achieving greater autonomy in the pharmaceutical sector, aligning with regional goals for self-sufficiency in medical supplies.
The initiative underscores the government’s commitment to investing in local industrial capabilities to address public health challenges. By fostering domestic production, Cameroon aims to mitigate the risks associated with global supply disruptions and improve access to affordable medications for its population.
This development is part of a wider effort to diversify the economy and create high-value jobs in the industrial sector. The completion of the Meyo pharmaceutical plant is expected to serve as a cornerstone for future health-related manufacturing projects in the region.
<small>Source: Actu Cameroun — read the original story there.</small>
